Screening for liver fibrosis in primary care: Focus on subjects above 40 and with metabolic risk factors.
作者信息
Castera Laurent
机构信息
Department of Hepatology, University of Paris, Paris, France.
出版信息
United European Gastroenterol J. 2021 Oct;9(8):889-891. doi: 10.1002/ueg2.12120. Epub 2021 Jul 6.
Abstract
摘要
相似文献
1
Screening for liver fibrosis in primary care: Focus on subjects above 40 and with metabolic risk factors.基层医疗中肝纤维化的筛查：关注40岁以上及有代谢危险因素的人群。
United European Gastroenterol J. 2021 Oct;9(8):889-891. doi: 10.1002/ueg2.12120. Epub 2021 Jul 6.
2
Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.在初级保健中通过MRI和MRE对糖尿病患者进行非侵入性筛查以检测非酒精性脂肪性肝病和肝纤维化进展情况。
Aliment Pharmacol Ther. 2016 Jan;43(1):83-95. doi: 10.1111/apt.13405. Epub 2015 Sep 15.
3
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.瞬时弹性成像用于肝纤维化筛查：来自欧洲和亚洲六个前瞻性队列的成本效益分析。
J Hepatol. 2019 Dec;71(6):1141-1151. doi: 10.1016/j.jhep.2019.08.019. Epub 2019 Aug 27.
4
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.经瞬时弹性成像定义的非酒精性脂肪性肝病患者中显著纤维化的患病率及预测因素
Dig Dis Sci. 2017 Aug;62(8):2150-2158. doi: 10.1007/s10620-017-4592-0. Epub 2017 May 18.
5
Non-invasive diagnosis of advanced fibrosis and cirrhosis.晚期纤维化和肝硬化的非侵入性诊断
World J Gastroenterol. 2014 Dec 7;20(45):16820-30. doi: 10.3748/wjg.v20.i45.16820.
6
Personalized management of cirrhosis by non-invasive tests of liver fibrosis.通过肝纤维化的非侵入性检测对肝硬化进行个性化管理。
Clin Mol Hepatol. 2015 Sep;21(3):200-11. doi: 10.3350/cmh.2015.21.3.200. Epub 2015 Sep 30.
7
Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis.瞬时弹性成像和二维剪切波弹性成像可用于评估酒精性肝纤维化和肝硬化。
Gastroenterology. 2016 Jan;150(1):123-33. doi: 10.1053/j.gastro.2015.09.040. Epub 2015 Oct 3.
8
Psoriasis and liver fibrosis: an investigation using transient elastography in Tunisian patients with psoriasis.银屑病与肝纤维化：一项针对突尼斯银屑病患者使用瞬时弹性成像技术的调查。
Br J Dermatol. 2019 Dec;181(6):1306-1308. doi: 10.1111/bjd.18177. Epub 2019 Sep 2.
9
Outreach screening of drug users for cirrhosis with transient elastography.应用瞬时弹性成像技术对药物使用者进行肝硬化的外展筛查。
Addiction. 2011 May;106(5):970-6. doi: 10.1111/j.1360-0443.2010.03246.x. Epub 2010 Dec 23.
10
[The FibroScan: a new non invasive method of liver fibrosis evaluation].[FibroScan：一种评估肝纤维化的新型非侵入性方法]
Rev Med Liege. 2007;62 Spec No:68-72.
本文引用的文献
1
High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort.瞬时弹性成像检测到的高肝硬度值与西班牙大样本队列中的代谢综合征和有害饮酒相关。
United European Gastroenterol J. 2021 Oct;9(8):892-902. doi: 10.1002/ueg2.12109. Epub 2021 Jun 2.
2
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究：1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担：系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.
3
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.英国年轻人脂肪性肝病和肝纤维化的流行情况：一项基于人群的研究。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):295-305. doi: 10.1016/S2468-1253(19)30419-4. Epub 2020 Jan 15.
4
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.前瞻性评估非酒精性脂肪性肝病患者的初级保健转诊途径。
J Hepatol. 2019 Aug;71(2):371-378. doi: 10.1016/j.jhep.2019.03.033. Epub 2019 Apr 6.
5
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
6
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝脏疾病的无创评估。
Gastroenterology. 2019 Apr;156(5):1264-1281.e4. doi: 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18.
7
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
8
Non-alcoholic fatty liver disease and the interface between primary and secondary care.非酒精性脂肪性肝病与初级保健和二级保健之间的关系。
Lancet Gastroenterol Hepatol. 2018 Jul;3(7):509-517. doi: 10.1016/S2468-1253(18)30077-3.
9
High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study.欧洲不明肝脏疾病成年患者中肝纤维化的高患病率：一项基于人群的研究。
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1138-1145.e5. doi: 10.1016/j.cgh.2017.12.048. Epub 2018 Feb 13.
10
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography.肥胖和 2 型糖尿病是一般实践中未确诊肝硬化的重要潜在危险因素：使用瞬时弹性成像的横断面研究。
Aliment Pharmacol Ther. 2018 Feb;47(4):504-515. doi: 10.1111/apt.14463. Epub 2017 Dec 6.
Zotero 插件